Louis$1M$294M$600K-2M$970K-2.3MCole TaylorMerrill Wealth ManagementSt
Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy

Features Benefits: How to use: Major Ingredients Water, Glycerin, Pentylene Glycol, Niacinamide, 2,3-Butanediol, 1,2-Hexanediol, Glutathione, Betaine, Tromethamine, Gluconolactone, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Ethylhexylglycerin, Sodium Citrate, Sodium Hyaluronate, Sphingomonas Ferment Extract, Citric Acid, 3-O-Ethyl Ascorbic Acid, Melia Azadirachta Flower Extract, Ocimum Sanctum Leaf Extract, Melia Azadirachta Leaf Extract, Curcuma Longa (Turmeric) Root Extract, Corallina Officinalis Extract, Sodium Hyaluronate Crosspolymer, Butylene Glycol, Hydrogenated Lecithin, Xylose, Polyglutamic Acid, Tocopherol, Cholesterol, Dipotassium Glycyrrhizate, Glycine, Cysteine, Sodium Cocoyl Isethionate, Helianthus Annuus (Sunflower) Seed Oil Ingredients subject to change at manufacturer's discretion
Tocris Bioscience Peptide solubility guidelines acetic acid for basic peptides, ammonium hydroxide for acidic peptides